TrialThe European respiratory journal2026

Mepolizumab for the treatment of refractory chronic cough in patients with eosinophilic airways disease (MUCOSA): a randomised, double-blind, parallel-group, placebo-controlled trial.

Nermin Diab et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.